SAT0248 Baseline clasi-damage is a major predictor of skin response to belimumab in a multicentric cohort of sle patients
Author:
M Gatto,L Iaccarino,L Andreoli,F Conti,R De Angelis,S De Vita,L Emmi,R Gerli,M Govoni,M Mosca,C Salvarani,A Tincani,A Doria
Publication:
Annals of Rheumatic Diseases
Copyright © 2017 © 2017, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.